2m 2m 2m 2m 2m 2m 2m
HUMACYTE (HUMA)
NASDAQ
$1.40-$0.005 (-0.36%)
Price as of Jun 03, 2026 7:54 PM EDT- $288.6MMarket Cap
- -46.74%1-Year Change
- BiotechnologyIndustry
HUMACYTE (HUMA)
$1.40-$0.005 (-0.36%)
HUMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.40 | ||
Change | -$0.06 (-4.14%) | ||
Open | $1.42 | ||
High | $1.46 | ||
Low | $1.35 | ||
Previous Close | $1.39 | ||
Volume | 5,494,364 | ||
30-Day Average Volume | 7,875,053 | ||
1-Week Change | 25.23% | ||
1-Month Change | 62.52% | ||
1-Year Change | -46.74% | ||
3-Year Change | -60.85% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 222.0M | ||
Total Assets | $110.6M | ||
Market Cap | $288.6M | ||
Enterprise Value | $276.0M | ||
Period: QTR TTM FY | |||
Revenue | $493,000.00 | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$25.3M | ||
EBIT | -$17.5M | ||
EBITDA | -$16.2M | ||
Net Working Capital | $47.4M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | 560 | ||
P/B | 25 | ||
P/E | -14 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue